Edesa Biotech EBITDA Margin Growth & History (EDSA)
Edesa Biotech's ebitda margin was −1,929.22% for fiscal 2020.
View full Edesa Biotech company overviewEdesa Biotech annual ebitda margin history
2014
2015
2016
2017
2019
2020
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-09-30 | −1,929.22% | −1241.08 pp |
| 2019 | 2019-09-30 | −688.14% | — |
| 2017 | 2017-09-30 | −10,090.45% | −9716.24 pp |
| 2016 | 2016-09-30 | −374.21% | +176.62 pp |
| 2015 | 2015-09-30 | −550.83% | — |
| 2014 | 2014-08-31 | −1,494.15% | — |
Edesa Biotech quarterly ebitda margin
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q1.18
Q2.18
Q2.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-09-30 | −396,290.80% | −396142.86 pp |
| Q3 2020 | 2020-06-30 | −1,586.53% | +262064.47 pp |
| Q2 2020 | 2020-03-31 | −1,369.58% | — |
| Q1 2020 | 2019-12-31 | −1,023.45% | — |
| Q4 2019 | 2019-09-30 | −147.94% | — |
| Q2 2019 | 2019-06-30 | −263,651.00% | — |
| Q2 2018 | 2018-03-31 | −2,025.34% | −276.18 pp |
| Q1 2018 | 2017-12-31 | −6,543.52% | −5578.45 pp |
| Q2 2017 | 2017-03-31 | −1,749.17% | −1424.47 pp |
| Q1 2017 | 2016-12-31 | −965.07% | −703.89 pp |
| Q4 2016 | 2016-09-30 | −461.33% | — |
| Q3 2016 | 2016-06-30 | −635.31% | — |
| Q2 2016 | 2016-03-31 | −324.70% | — |
| Q1 2016 | 2015-12-31 | −261.18% | — |
Edesa Biotech ebitda margin trends
Over the last five fiscal years, Edesa Biotech's ebitda margin decreased from −550.83% to −1,929.22%, a change of −1378.39 percentage points. The latest reported quarter, Q4 2020, shows −396,290.80%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Edesa Biotech source filings ↗